Search companies on Owler
Advanced Search
Latest news
Newsfeed
My followed companies
Followed Companies

Tusk Therapeutics develops and commercializes therapeutic antibodies for the treatment of cancer. Read more

1 Followers on Owler
1 Followers on Owler
1 Followers on Owler
1 Followers on Owler

Tusk Therapeutics develops and commercializes therapeutic antibodies for the treatment of cancer. Read more

Luc Dochez's photo - CEO of Tusk Therapeutics

CEO

Luc Dochez

CEO Approval Rating

70/100

Founded:

2015

Status:

PrivateSubsidiary of F. Hoffmann-La Roche Ltd.

SIC Code:

2836 NAICS listing »

Est. Annual Revenue
Est. Employees
Sector
Biotechnology
Headquarters

TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Missing a competitor? Contribute!

The top 10 competitors in Tusk Therapeutics' competitive set are Kymab, Crescendo Biologics, F-star, Apexigen, NovImmune, Bicycle, Jounce, NexImmune, Tiziana, Alder BioPharmaceuticals. Together they have raised over 2.8B between their estimated 1.4K employees. Tusk Therapeutics's revenue is the ranked 10th among it's top 10 competitors. The top 10 competitors average 19.1M. Tusk Therapeutics has 25 employees and is ranked lowest among it's top 10 competitors. The top 10 competitors average 76.

Kymab is Tusk Therapeutics's top competitor. Kymab is a Private company that was founded in Cambridge, England in 2009. Kymab operates in the Pharmaceuticals industry. Kymab has 149 more employees vs. Tusk Therapeutics.

Crescendo Biologics has been one of Tusk Therapeutics's top competitors. Crescendo Biologics is headquartered in Cambridge, England, and was founded in 2007. Crescendo Biologics is in the Biotechnology field. Crescendo Biologics generates 87% the revenue of Tusk Therapeutics.

F-star is perceived as one of Tusk Therapeutics's biggest rivals. F-star was founded in 2006 in Cambridge, England. F-star competes in the Biotechnology field. F-star generates $16.7M more revenue than Tusk Therapeutics.

Weigh-in!

Help the Owler community know more

Growth Score - 1/1

Is $7M a good estimate for Tusk Therapeutics's revenue?

I don't know

Trending News for Tusk Therapeutics and Tusk Therapeutics's Competitors

January 20, 2021

Asian Venture Capital Journal

Deal focus: Monetizing mice

ORI Capital's 2.8x return on its investment in Kymab was in part based on helping the company make th... See more »

January 20, 2021

Seeking Alpha

F-Star secures European patent for FS118 in cancer

See more »

January 21, 2021

FE Investegate

AIM : Cancellation - Tiziana Life Sciences PLC

8:00 AM: Cancellation - Tiziana Life Sciences PLC... See more »

Acquisitions

No recent acquisitions found related to Tusk Therapeutics

Tusk Therapeutics Funding History

$3.3M

Since Tusk Therapeutics was founded in 2015, it has participated in 1 round of funding. In total Tusk Therapeutics has raised $3.3M. Tusk Therapeutics' funding round was on Nov 2017 for a total of $3.3M

ROUND

FUNDING DATE

AMOUNT

INVESTORS

Grant
Nov 2017
$3.3M
-

Total Funding: $3.3M

Since Tusk Therapeutics was founded in 2015, it has participated in 1 round of funding. In total Tusk Therapeutics has raised $3.3M. Tusk Therapeutics' funding round was on Nov 2017 for a total of $3.3M

Investments

No recent investments found related to Tusk Therapeutics

Tusk Therapeutics News

Social Media

Headquarters

Gunnels Wood Road, Hertfordshire

Stevenage, EnglandSG1 2FX

Driving Directions »

Trending Companies

Summary

ABOUT

Overview

Tusk Therapeutics develops and commercializes therapeutic antibodies for the treatment of cancer. Tusk Therapeutics was founded in 2015. Tusk Therapeutics' headquarters is located in Stevenage, England, GB SG1 2FX. It has raised 3.3M in 1 round. The l...

CEO

Tusk Therapeutics's CEO, Luc Dochez, currently has an approval rating of 70%. Tusk Therapeutics's primary competitors are Kymab, Crescendo Biologics & F-star.

Website

tusktherapeutics.com

Frequently Asked Questions about Tusk Therapeutics

  1. When was Tusk Therapeutics founded?

    Tusk Therapeutics was founded in 2015

  2. Who is Tusk Therapeutics's CEO?

    Tusk Therapeutics's CEO is Luc Dochez

  3. How much revenue does Tusk Therapeutics generate?

    Tusk Therapeutics generates $7M in revenue

  4. How much funding does Tusk Therapeutics have?

    Tusk Therapeutics has historically raised $3.3M in funding

  1. Where is Tusk Therapeutics's headquarters?

    Tusk Therapeutics's headquarters is in Stevenage England, GB

  2. How many employees does Tusk Therapeutics have?

    Tusk Therapeutics has 25 employees

  3. What sector does Tusk Therapeutics operate in?

    Tusk Therapeutics is in Biotechnology

  4. Who are Tusk Therapeutics's competitors?

    Tusk Therapeutics's top competitors are Kymab, Crescendo Biologics, F-star
Stay up-to-date with the latest news on Tusk Therapeutics

© 2021 Owler, Inc.